Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival—a study from the groupe d' …
E Bachy, P Brice, R Delarue, N Brousse… - Journal of clinical …, 2010 - ascopubs.org
Purpose First-line treatment for patients with newly diagnosed follicular lymphoma (FL) still
remains debated, even in the rituximab-based combination therapy era. Few studies have …
remains debated, even in the rituximab-based combination therapy era. Few studies have …
Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival--A study from the groupe d' …
E Bachy, P Brice, R Delarue, N Brousse… - Journal of Clinical …, 2009 - europepmc.org
PURPOSE First-line treatment for patients with newly diagnosed follicular lymphoma (FL)
still remains debated, even in the rituximab-based combination therapy era. Few studies …
still remains debated, even in the rituximab-based combination therapy era. Few studies …
Long-Term Follow-Up of Patients With Newly Diagnosed Follicular Lymphoma in the Prerituximab Era: Effect of Response Quality on Survival—A Study From the …
E Bachy, P Brice, R Delarue, N Brousse… - Journal of Clinical …, 2010 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> First-line treatment for patients with
newly diagnosed follicular lymphoma (FL) still remains debated, even in the rituximab-based …
newly diagnosed follicular lymphoma (FL) still remains debated, even in the rituximab-based …
Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: Effect of response quality on survival-A study from the groupe d' …
E Bachy, P Brice, R Delarue, N Brousse… - Journal of Clinical …, 2010 - dial.uclouvain.be
Purpose: First-line treatment for patients with newly diagnosed follicular lymphoma (FL) still
remains debated, even in the rituximab-based combination therapy era. Few studies have …
remains debated, even in the rituximab-based combination therapy era. Few studies have …
[引用][C] Long-Term Follow-Up of Patients With Newly Diagnosed Follicular Lymphoma in the Prerituximab Era: Effect of Response Quality on Survival—A Study From …
E BACHY, P BRICE, C ALLARD… - Journal of clinical …, 2010 - pascal-francis.inist.fr
Long-Term Follow-Up of Patients With Newly Diagnosed Follicular Lymphoma in the
Prerituximab Era: Effect of Response Quality on Survival—A Study From the Groupe d'Etude …
Prerituximab Era: Effect of Response Quality on Survival—A Study From the Groupe d'Etude …
Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival--A study from the groupe d' …
E Bachy, P Brice, R Delarue… - Journal of clinical …, 2010 - pubmed.ncbi.nlm.nih.gov
PURPOSE First-line treatment for patients with newly diagnosed follicular lymphoma (FL)
still remains debated, even in the rituximab-based combination therapy era. Few studies …
still remains debated, even in the rituximab-based combination therapy era. Few studies …
Long-Term Follow-Up of Patients With Newly Diagnosed Follicular Lymphoma in the Prerituximab Era: Effect of Response Quality on Survival--A Study From the …
E Bachy, P Brice, R Delarue, N Brousse… - Journal of Clinical …, 2009 - hal.science
PURPOSE: First-line treatment for patients with newly diagnosed follicular lymphoma (FL)
still remains debated, even in the rituximab-based combination therapy era. Few studies …
still remains debated, even in the rituximab-based combination therapy era. Few studies …
[引用][C] Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival-a study from the Groupe …
E BACHY - J Clin Oncol., 2010 - cir.nii.ac.jp
Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab
era : effect of response quality on survival-a study from the Groupe d'Etude des Lymphomes …
era : effect of response quality on survival-a study from the Groupe d'Etude des Lymphomes …